Articles

Living Labs is working with partners to bring people-centered health systems across the region.

Most of the world’s vaccine manufacturing capacity is in high-income countries, creating barriers to access for countries with fewer economic resources. Learn how PATH is supporting low- and middle-income country vaccine manufacturers as they work to bring vaccines to the global market.

With 34 team members, 95% of whom are based in the countries where we work, we are actively working on 32 projects and have a network of more than 4,000 users.

Burkina Faso introduced typhoid conjugate vaccines (TCVs), becoming the first in Francophone Africa to include TCVs in the routine childhood immunization schedule.